DECIPHERA PHARMACEUTICALS IN (DCPH)

US24344T1016 - Common Stock

25.38  +0.02 (+0.08%)

After market: 25.38 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
163.36M134.04M96.15M42.09M25.00M
Cost Of Goods
3.73M8.77M2.93M225.00KN/A
Gross Profit
159.62M125.27M93.22M41.86MN/A
Operating Expenses
370.58M307.99M393.29M313.05M225.73M
Research and Development
234.12M187.82M257.04M198.97M157.61M
Selling, General, and Administrative Expenses
136.46M120.17M136.25M114.08M68.12M
Operating Income
-210.96M-182.72M-300.08M-271.19M-200.73M
Interest Income/Expense
16.45M4.51M113.00K4.70M8.47M
Income Before Taxes
-194.51M-178.21M-299.96M-266.49M-192.26M
Income Tax
431.00K722.00KN/AN/AN/A
Net Income
-194.94M-178.93M-299.96M-266.49M-192.26M
EBITDA
-208.86M-179.78M-297.06M-268.88M-199.90M
 
Per Share Data
EPS Diluted Total Ops
-2.29-2.37-5.16-4.78-4.48
Non GAAP EPS
-2.29-2.55-5.15-4.79-4.40
 
Statistics
Gross Profit Margin
97.72%93.46%96.95%99.47%N/A
Profit Margin
-119.34%-133.49%-311.98%-633.19%-769.02%
Operating Profit Margin
-129.14%-136.32%-312.10%-644.36%-802.90%

All data in USD

Charts